Evidence map›Paper›PMID 34028766›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

Transformation of the Plastid Genome in Tobacco: The Model System for Chloroplast Genome Engineering.

Pal Maliga, Tarinee Tungsuchat-Huang, Kerry Ann Lutz

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Rewinding evolution in planta: A Rubisco-null platform validates high-performance ancestral enzymes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Pal MaligaWaksman Institute of Microbiology, Rutgers University, Piscataway, NJ, USA. maliga@waksman.rutgers.edu.
Tarinee Tungsuchat-HuangWaksman Institute of Microbiology, Rutgers University, Piscataway, NJ, USA.
Kerry Ann LutzBiology Department, Farmingdale State College, Farmingdale, NY, USA.
Rutgers, The State University of New Jersey · USFarmingdale State College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protocol we report here is based on biolistic delivery of transforming DNA to tobacco leaves, selection of transplastomic clones by spectinomycin or kanamycin resistance and regeneration of plants with uniformly transformed plastid genomes. Because the plastid genome of Nicotiana tabacum derives from Nicotiana sylvestris, and the two genomes are highly conserved, vectors developed for N. tabacum can be used in N. sylvestris. The tissue culture responses of N. tabacum cv. Petit Havana and N. sylvestris accession TW137 are similar. Plastid transformation in a subset of N. tabacum cultivars and in Nicotiana benthamiana requires adjustment of the tissue culture protocol. We describe updated vectors targeting insertions in the unique and repeated regions of the plastid genome, vectors suitable for regulated gene expression by the engineered PPR10 RNA binding protein as well as systems for marker gene excision.

Indexed as

Genome, ChloroplastGenome, PlastidTransformation, GeneticTransgenesGenetic MarkersKanamycin ResistanceNicotianaPlants, Genetically ModifiedPlastidsSpectinomycinGenetic MarkersSpectinomycinAADAminoglycoside-3″-adenylyltransferaseGFPKanamycin selectionNeomycin phosphotransferaseNicotiana sylvestrisNicotiana tabacumNPTIISpectinomycin selectionTobacco

Identifiers

PMID34028766
OpenAlexW3164074861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.